LC
MDT icon

Landaas & Company’s Medtronic MDT Stock Holding History

Landaas & Company’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-825
Closed -$71K – 210
2018
Q2 		$71K Buy
+825
New +$68.9K 0.06% 118
2018
Q1 		– Sell
-825
Closed -$67K – 205
2017
Q4 		$67K Sell
825
-2,630
-76% -$211K 0.06% 120
2017
Q3 		$269K Buy
+3,455
New +$287K 0.24% 44

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Landaas & Company's MDT Position: Q3 2018 in Review

Landaas & Company sold out of Medtronic (MDT) in Q3 2018, closing a stake of 825 shares — an estimated $71K sold.

Landaas & Company first reported a position in MDT in Q3 2017 and held it in 3 quarters. The position peaked at $269K in Q3 2017. 1,484 funds tracked by Wall St. Rank hold MDT as of Q3 2018.

  • Landaas & Company reported no remaining Medtronic position as of Q3 2018 after selling out during the quarter.
  • Landaas & Company sold 825 Medtronic shares in Q3 2018, an estimated $71K.
  • Landaas & Company first reported a position in Medtronic in Q3 2017 and held it in 3 quarters.
  • Landaas & Company's Medtronic position peaked at $269K in Q3 2017.
  • 1,484 funds tracked by Wall St. Rank held Medtronic as of Q3 2018.

Based on Landaas & Company's 13F filing for Q3 2018, filed 14 Nov 2018.